[Results of combined therapy of stable 2-3 FC angina of effort with metabolic syndrome including metformin].
The aim of the study was to evaluate results of combined therapy of stable 2-3 FC angina of effort with metabolic syndrome including metformin. Group 1 was comprised of 71 patients (38 (53.3%) men and 33 (46.5%) women), group 2 consisted of 57 patients treated with isosorbid-5 mononitrate (40 mg/d + amlodipin (5 mg/d) + eprosartan (600 mg/d) + thrombo ASS (100 mg/d) + carvedilol (25 mg/d) + atorvastatin (20 mg/d). Effects of the treatment were assessed 3, 6, and 12 months after its onset. At the end of the study, fasting blood glucose, total cholesterol, triglyceride, and low density lipoproteide levels decreased by 12.8, 10.9, 12.9 and 13.6% respectively compared with the initial values (p < 0.01). The level of high density lipoproteides increased by 10.4% (p < 0.01). Supplementation of therapy with metformin (1000 mg) decreased the frequency of episodes of painful and painless myocardial ischemia by 17.0 and 21.1%. Simultaneously, tolerance of physical load increased by 22.7%.